Expression Vector

Abstract

An expression vector for expressing a target polypeptide in a prokaryotic cell is provided. The vector comprises a promoter operably linked to a polynucleotide encoding the target polypeptide operably linked to a eukaryotic secretion leader sequence, the eukaryotic secretion leader sequence encoding a signal peptide sequence selected from the group consisting of: a) MLKRSSWLATLGLLTVASVSTIVYA; b) MKKATFITCLLAVLLVSNPIWNA; c) MKVSAAALAVILIATALCAPASA; d) MKVSTAFLCLLLTVSAFSAQVLA; and e) MKCLLLALGLALACAAQA. Processes for expressing polypeptides and prokaryotic microorganisms comprising such vectors are also provided.

1 - 14 . (canceled) 
     
     
         15 . A prokaryotic expression vector comprising a prokaryotic promoter operably linked to a heterologous polynucleotide encoding a target polypeptide operably linked to a eukaryotic secretion leader, the eukaryotic secretion leader encoded by the polynucleotide being a signal peptide having an amino acid sequence at least 90% identical to SEQ ID NO: 2, 3 or 5. 
     
     
         16 . The prokaryotic expression vector according to  claim 15 , wherein the signal peptide has an amino acid sequence at least 95% identical with SEQ ID NO: 2, 3 or 5. 
     
     
         17 . The prokaryotic expression vector according to  claim 15 , wherein the polynucleotide encoding a target polypeptide operably linked to a eukaryotic secretion leader sequence has structure such that the polynucleotide encoding the eukaryotic secretion leader sequence is attached at the 5′ end of the polynucleotide encoding the target polypeptide. 
     
     
         18 . The prokaryotic expression vector according to  claim 15 , wherein the vector is a plasmid. 
     
     
         19 . The prokaryotic expression vector according to  claim 15 , wherein the target polypeptide is selected from the group consisting of cytokines, growth factors, antibodies, antibody fragments, immunoglobulin like polypeptides, enzyme, vaccines, peptide hormones, chemokines, receptors, receptor fragments, kinases, phosphatases, isomerases, hydrolyases, transcription factors and fusion polypeptides. 
     
     
         20 . A method for the production of a target polypeptide which comprises expressing the prokaryotic expression vector according to  claim 15  in a prokaryotic host cell. 
     
     
         21 . The method according to  claim 20 , wherein the prokaryotic host cell is selected from the group consisting of  E. coli, Salmonella typhimurium, Serratia marsescens, Pseudomonas aeruginosa, Pseudomonas putida  and  Bacillus subtilis.    
     
     
         22 . A prokaryotic microorganism comprising the prokaryotic expression vector according to  claim 15 . 
     
     
         23 . The prokaryotic microorganism according to  claim 22 , wherein the microorganism is selected from the group consisting of  E. coli, Salmonella typhimurium, Serratia marsescens, Pseudomonas putida, Pseudomonas aeruginosa,  and  Bacillus subtilis.    
     
     
         24 . A method for producing a target polypeptide which comprises:
 a) culturing a prokaryotic host cell comprising the prokaryotic expression vector according to  claim 15 , thereby to express the target polypeptide, and   b) recovering the target polypeptide.   
     
     
         25 . The method according to  claim 24 , wherein the polynucleotide encoding the target polypeptide operably linked to the eukaryotic secretion leader sequence has structure such that the polynucleotide encoding the eukaryotic secretion leader sequence is attached at the 5′ end of the polynucleotide encoding the target polypeptide. 
     
     
         26 . The method according to  claim 24 , wherein the target polypeptide is selected from the group consisting of cytokines, growth factors, antibodies, antibody fragments, immunoglobulin like polypeptides, enzyme, vaccines, peptide hormones, chemokines, receptors, receptor fragments, kinases, phosphatases, isomerases, hydrolyases, transcription factors and fusion polypeptides. 
     
     
         27 . The method according to  claim 24 , wherein the signal peptide has the sequence of SEQ ID NO: 2, 3 or 5. 
     
     
         28 . The method according to  claim 24 , wherein the prokaryotic host cell is selected from the group consisting of  E. coli, Salmonella typhimurium, Serratia marsescens, Pseudomonas aeruginosa, Pseudomonas putida  and  Bacillus subtilis.    
     
     
         29 . The method according to  claim 28 , wherein the signal peptide has the sequence of SEQ ID NO: 2, 3 or 5. 
     
     
         30 . The method according to  claim 24 , wherein the prokaryotic promoter is an  E. coli  polymerase-based promoter. 
     
     
         31 . The prokaryotic expression vector according to  claim 15 , wherein the signal peptide has the amino acid sequence at least 90% identical with SEQ ID NO: 2. 
     
     
         32 . The prokaryotic expression vector according to  claim 15 , wherein the signal peptide has the amino acid sequence at least 90% identical with SEQ ID NO: 3. 
     
     
         33 . The prokaryotic expression vector according to  claim 15 , wherein the signal peptide has the amino acid sequence at least 90% identical with SEQ ID NO: 5. 
     
     
         34 . The prokaryotic expression vector according to  claim 15 , wherein the signal peptide has the amino acid sequence of SEQ ID NO: 2, 3 or 5.